It is most frequently found in Lung Adenocarcinomas (LUAD), especially in KRAS and BRAF wild-type cases.33, 34 NRG1 is an oncogene that has attracted increased interest in recent years and serves as a potential therapeutic target.35 This evidence concerns the gene KRAS and lung adenocarcinoma.